STOCK TITAN

Tang Capital discloses 1.92% Evolus (EOLS) ownership in Schedule 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Tang Capital Management and related entities reported beneficial ownership of Evolus, Inc. common stock totaling 1,245,692 shares, representing 1.92% of the outstanding class. These shares are held with shared, not sole, voting and dispositive power across several Tang-affiliated funds and entities.

The ownership is spread among Tang Capital Partners, Tang Capital Partners International, Tang Capital Partners III, and Tang Capital Partners IV, with Kevin Tang sharing voting and investment authority. The filing notes that the securities are not held for the purpose of changing or influencing control of Evolus.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Tang Capital Management, LLC ("TCM") shares voting and dispositive power over such shares with Tang Capital Partners, LP ("TCP"), Tang Capital Partners International, LP ("TCPI"), Tang Capital Partners III, Inc. ("TCP III"), Tang Capital Partners IV, Inc. ("TCP IV") and Kevin Tang. The percentages used herein are based on 64,819,784 shares of Common Stock outstanding as of October 31, 2025, as set forth in the Issuer's Quarterly Report filed on Form 10-Q that was filed with the Securities and Exchange Commission on November 5, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Kevin Tang shares voting and dispositive power over such shares with TCP, TCPI, TCP III, TCP IV and TCM.


SCHEDULE 13G




Comment for Type of Reporting Person: TCP shares voting and dispositive power over such shares with TCM and Kevin Tang.


SCHEDULE 13G




Comment for Type of Reporting Person: TCPI shares voting and dispositive power over such shares with TCM and Kevin Tang.


SCHEDULE 13G




Comment for Type of Reporting Person: TCP III shares voting and dispositive power over such shares with TCM and Kevin Tang.


SCHEDULE 13G




Comment for Type of Reporting Person: TCP IV shares voting and dispositive power over such shares with TCM and Kevin Tang.


SCHEDULE 13G



TANG CAPITAL MANAGEMENT, LLC
Signature:/s/ Kevin Tang
Name/Title:Manager
Date:02/17/2026
KEVIN TANG
Signature:/s/ Kevin Tang
Name/Title:Self
Date:02/17/2026
TANG CAPITAL PARTNERS, LP
Signature:/s/ Kevin Tang
Name/Title:Manager, Tang Capital Management, LLC, General Partner
Date:02/17/2026
TANG CAPITAL PARTNERS INTERNATIONAL, LP
Signature:/s/ Kevin Tang
Name/Title:Manager, Tang Capital Management, LLC, General Partner
Date:02/17/2026
TANG CAPITAL PARTNERS III, INC
Signature:/s/ Kevin Tang
Name/Title:Chief Executive Officer
Date:02/17/2026
TANG CAPITAL PARTNERS IV, INC
Signature:/s/ Kevin Tang
Name/Title:Chief Executive Officer
Date:02/17/2026

FAQ

What percentage of Evolus (EOLS) does Tang Capital currently beneficially own?

Tang Capital and affiliated entities beneficially own 1,245,692 shares of Evolus, Inc., representing 1.92% of the common stock. This percentage is based on 64,819,784 shares outstanding as of October 31, 2025, as disclosed in Evolus’s quarterly report.

How many Evolus (EOLS) shares are reported under shared voting power by Tang entities?

The filing reports 1,245,692 Evolus shares under shared voting power across Tang Capital Management and related entities. None of these shares are held with sole voting power, indicating decisions are made jointly among the affiliated entities and Kevin Tang.

Does Tang Capital report owning more or less than 5% of Evolus (EOLS)?

Tang Capital and its affiliates report ownership of 5 percent or less of Evolus common stock. Item 5 of the Schedule 13G/A confirms ownership of 5 percent or less of the class, with the disclosed stake at 1.92% of outstanding shares.

Who are the reporting persons in the Evolus (EOLS) Schedule 13G/A filing?

Reporting persons include Tang Capital Management, LLC, Kevin Tang, Tang Capital Partners, Tang Capital Partners International, Tang Capital Partners III, and Tang Capital Partners IV. These entities share voting and dispositive power over the reported Evolus shares, as outlined in the ownership tables.

What type of Evolus (EOLS) securities are reported in this Schedule 13G/A?

The filing covers common stock of Evolus, Inc. with a par value of $0.00001 per share, identified by CUSIP 30052C107. All ownership figures, percentages, and voting power disclosures in the amendment relate to this class of Evolus common stock.

Does Tang Capital state an intent to influence control of Evolus (EOLS)?

The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of Evolus. It also notes they are not held in connection with any transaction having that purpose, except activities solely tied to a nomination under Rule 14a-11.
Evolus

NASDAQ:EOLS

EOLS Rankings

EOLS Latest News

EOLS Latest SEC Filings

EOLS Stock Data

278.73M
53.54M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
NEWPORT BEACH